PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology
Eastwood, Stephanie M, Meyer, Matthew R, Kirmess, Kristopher M, Wente-Roth, Traci L, Irvin, Faith, Holubasch, Mary S, Verghese, Philip B, West, Tim, Braunstein, Joel B, Yarasheski, Kevin E, Contois, John H
Published in Diagnostics (Basel) (01.08.2024)
Published in Diagnostics (Basel) (01.08.2024)
Get full text
Journal Article
Plasma ratio of phospho‐ to non‐phospho‐tau at threonine 217 identifies brain amyloid burden as measured by quantitative amyloid PET in the PARIS sub‐study of IDEAS
Meyer, Matthew R., Kirmess, Kristopher M., Wente‐Roth, Traci L., Irvin, Faith, Holubasch, Mary S., Verghese, Philip B., Monane, Mark, Bateman, Randall J., Holtzman, David M., Venkatesh, Venky, Fogelman, Ilana, Yarasheski, Kevin E., Braunstein, Joel B., West, Tim
Published in Alzheimer's & dementia (01.12.2022)
Published in Alzheimer's & dementia (01.12.2022)
Get full text
Journal Article
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid
Meyer, Matthew R., Kirmess, Kristopher M., Eastwood, Stephanie, Wente‐Roth, Traci L., Irvin, Faith, Holubasch, Mary S., Venkatesh, Venky, Fogelman, Ilana, Monane, Mark, Hanna, Lucy, Rabinovici, Gil D., Siegel, Barry A., Whitmer, Rachel A., Apgar, Charles, Bateman, Randall J., Holtzman, David M., Irizarry, Michael, Verbel, David, Sachdev, Pallavi, Ito, Satoshi, Contois, John, Yarasheski, Kevin E., Braunstein, Joel B., Verghese, Philip B., West, Tim
Published in Alzheimer's & dementia (01.05.2024)
Published in Alzheimer's & dementia (01.05.2024)
Get full text
Journal Article